Updates are available Correction dated 2020-10-30
Click to view Correction: https://doi.org/10.1007/s11136-020-02659-3
-
Authors
Pfeiffer, Kathryn M. http://orcid.org/0000-0003-2186-6340
Brod, Meryl http://orcid.org/0000-0002-0663-5838
Smith, Alden http://orcid.org/0000-0003-1582-534X
Gianettoni, Jill
Viuff, Dorthe
Ota, Sho http://orcid.org/0000-0001-5786-8423
Charlton, R. Will http://orcid.org/0000-0001-8451-9165
-
Funding
Funding for this research was provided by:
Ascendis Pharma Growth Disorders A/S
- License Information
-
More Information
Article History
Accepted: 23 July 2020
First Online: 16 August 2020
Change Date: 30 October 2020
Change Type: Correction
Change Details: In the original publication, the summary statistics for child BMI in Tables 2 and 8 were incorrect. The correct version of tables (with updated summary statistics) are provided in this correction.
Compliance with ethical standards
:
: K. Pfeiffer and M. Brod are consultants to the pharmaceutical industry including Ascendis Pharma. A. Smith, S. Ota, and R.W. Charlton are employees of Ascendis Pharma, Inc. D Viuff is an employee of Ascendis Pharma, A/S. J. Gianettoni was an employee of Ascendis Pharma, Inc. when the research was conducted.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (Copernicus Group Institutional Review Board; Protocol numbers: TBG1-18-117 and 20190578) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
